Novosti
|
This journal is indexed in Scopus |
---|
Year 2020 Vol. 28 No 1
SCIENTIFIC PUBLICATIONS
GENERAL & SPECIAL SURGE
S.G. ALI-ZADE, SH.K. NAZAROV, P.K. KHOLMATOV
TIM-3 LEVEL IN BLOOD SERUM IN ACUTE PANCREATITIS IN EARLY STAGE
Tajik State Medical University, Dushanbe,
The Republic of Tajikistan
Objective. To study the expression of the serum TIM-3 (sTIM-3) in patients with acute pancreatitis in the early stage.
Methods. 44 patients with acute pancreatitis were examined who were admitted to the surgical departments of the city clinical emergency hospital in Dushanbe in the period from 2017 to 2019. The 1st group included 16 patients with mild acute pancreatitis; the 2nd group included 28 patients with moderate to severe acute pancreatitis. The control group (CG) consisted of 20 healthy volunteers. In the studied patients, the disease severity was assessed according to the APACHE II scale, the level of sTIM-3 in the blood serum and the levels of cytokines IL-6, IL-10 and TNF-α were established with the determination of the correlation between them.
Results. The levels of IL-6 and TNF-α were significantly higher in the 2nd group of patients with severe acute pancreatitis than in the 1st group of patients and the control group. The level of IL-10 in the 2nd group was significantly lower than in the 1st group. The sTIM-3 indices in the 1st and 2nd groups of patients were significantly higher than in the control group. In turn, in patients of the 2nd group, the level of sTIM-3 was significantly higher than in the 1st group. A direct correlation between the level of sTIM-3 and the levels of IL-6 and TNF-α was revealed, whereas between sTIM-3 and the level of IL-10 no significant relationship was found. A direct correlation between the sTIM-3 level and the APACHE II score was determined (r=0.545, p<0.001).
Conclusions. It has been established that the level of sTIM-3 varies depending on the severity of acute pancreatitis, and inhibition of sTIM-3 activation can have a therapeutic effect on the excessive inflammatory response. Measurement of serum sTIM-3 may be an early marker for predicting acute pancreatitis.
- Johnson CD, Besselink MG, Carter R. Acute pancreatitis. BMJ. 2014 Aug 12;349:g4859. doi: 10.1136/bmj.g4859
- Hirota M, Nozawa F, Okabe A, Shibata M, Kuwata K, Ogawa M. SIRS and CARS: discussion based on the pathologic condition of acute pancreatitis. Rinsho Byori. 2000 Jun;48(6):527-32. [Article in Japanese]
- Duan L, Ma Y, Chi J, Wang X, Wesley AJ, Chen X. The regulatory role of immunosuppressants on immune abnormalities in acute pancreatitis. Biomed Rep. 2014 Mar;2(2):193-98. Published online 2013 Nov 29. doi: 10.3892/br.2013.208
- Li J, Yang WJ, Huang LM, Tang CW. Immunomodulatory therapies for acute pancreatitis. World J Gastroenterol. 2014 Dec 7; 20(45): 16935-47. Published online 2014 Dec 7. doi: 10.3748/wjg.v20.i45.16935
- Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013 Jun;144(6):1252-61. doi: 10.1053/j.gastro.2013.01.068
- Zhang Y, Ma CJ, Wang JM, Ji XJ, Wu XY, Moorman JP, Yao ZQ. Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes. J Leukoc Biol. 2012 Feb;91(2):189-96. doi: 10.1189/jlb.1010591
- Nebbia G, Peppa D, Schurich A, Khanna P, Singh HD, Cheng Y, Rosenberg W, Dusheiko G, Gilson R, ChinAleong J, Kennedy P, Maini MK. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One. 2012;7(10):e47648. doi: 10.1371/journal.pone.0047648
- Qiu MK, Wang SC, Dai YX, Wang SQ, Ou JM1, Quan ZW. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis. PLoS One. 2015 Jun 2;10(6):e0128523. doi: 10.1371/journal.pone.0128523. eCollection 2015.
- Yan WJ, Sun P, Wei DD, Wang SX, Yang JJ, Li YH, Zhang C. T cell immunoglobulin and mucin domain-containing molecule 3 on CD14+ monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes mellitus. J Diabetes Investig. 2016 Nov;7(6):867-73. doi: 10.1111/jdi.12523
- Ren F, Li J, Jiang X, Xiao K, Zhang D, Zhao Z, Ai J, Hou C, Jia Y, Han G, Xie L. Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes. Tissue Antigens. 2015 Nov;86(5):325-32. doi: 10.1111/tan.12653
- Chiba M, Yanaba K, Hayashi M, Yoshihara Y, Nakagawa H. Clinical significance of serum soluble T-cell immunoglobulin and mucin domain 3 levels in systemic sclerosis: Association with disease severity. J Dermatol. 2017 Feb;44(2):194-197. doi: 10.1111/1346-8138.13610
- Lesina M, Wörmann SM, Neuhöfer P, Song L, Algül H. Interleukin-6 in inflammatory and malignant diseases of the pancreas. Semin Immunol. 2014 Feb;26(1):80-87. doi: 10.1016/j.smim.2014.01.002
- Esposito E, Cuzzocrea S. TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem. 2009;16(24):3152-67. doi: 10.2174/092986709788803024
- Manohar M, Verma AK, Venkateshaiah SU, Sanders NL, Mishra A. Pathogenic mechanisms of pancreatitis. World J Gastrointest Pharmacol Ther. 2017 Feb 6;8(1):10-25. doi: 10.4292/wjgpt.v8.i1.10
- Malleo G, Mazzon E, Siriwardena AK, Cuzzocrea S. Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock. 2007 Aug;28(2):130-40. doi: 10.1097/shk.0b013e3180487ba1
- Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32(1):23-63. doi: 10.1615/CritRevImmunol.v32.i1.30
- Rathnakar SK, Vishnu VH, Muniyappa S, Prasath A. Accuracy and Predictability of PANC-3 Scoring System over APACHE II in Acute Pancreatitis: A Prospective Study. J Clin Diagn Res. 2017 Feb;11(2):PC10-PC13. doi: 10.7860/JCDR/2017/231689375
734003, Republic of Tajikistan,
Dushanbe, Rudaki Ave.,139,
Tajik State Medical University,
Surgical Diseases Department №1.
Tel. +992 928 21-77-55,
e-mail: suhrob_a@mail.ru,
Sukhrob G. Ali-Zade
Ali-Zade Sukhrob G., PhD, Assistant of the Surgical Diseases Department No1, Tajik State Medical University, Dushanbe, Republic of Tajikistan.
https://orcid.org/0000-0002-2456-7509
Nazarov Shohin K., MD, Professor, Head of the Surgical Diseases Department No1, Tajik State Medical University, Dushanbe, Republic of Tajikistan.
https://orcid.org/0000-0003-2099-2353
Kholmatov Pulat K., PhD, Associate Professor of the Surgical Diseases Department No1, Tajik State Medical University, Dushanbe, Republic of Tajikistan.
https://orcid.org/0000-0001-8025-0832